These findings suggest that RTA404 can inhibit proliferation, cell locomotion, cell cycle progression, and induce senescence in GBM cells in vitro, possibly though its inhibition of N-cadherin and E-cadherin expression via its inhibition of the AKT pathway. Here, AKT1 is linked to glioblastoma.